JP2013523827A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523827A5
JP2013523827A5 JP2013503881A JP2013503881A JP2013523827A5 JP 2013523827 A5 JP2013523827 A5 JP 2013523827A5 JP 2013503881 A JP2013503881 A JP 2013503881A JP 2013503881 A JP2013503881 A JP 2013503881A JP 2013523827 A5 JP2013523827 A5 JP 2013523827A5
Authority
JP
Japan
Prior art keywords
composition
substituent
amino
chitosan
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013503881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013523827A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/031385 external-priority patent/WO2011127144A1/en
Publication of JP2013523827A publication Critical patent/JP2013523827A/ja
Publication of JP2013523827A5 publication Critical patent/JP2013523827A5/ja
Pending legal-status Critical Current

Links

JP2013503881A 2010-04-06 2011-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物 Pending JP2013523827A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32143710P 2010-04-06 2010-04-06
US61/321,437 2010-04-06
US201161451430P 2011-03-10 2011-03-10
US61/451,430 2011-03-10
PCT/US2011/031385 WO2011127144A1 (en) 2010-04-06 2011-04-06 Methods and compositions for treating wounds utilizing chitosan compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015077340A Division JP6000397B2 (ja) 2010-04-06 2015-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物

Publications (2)

Publication Number Publication Date
JP2013523827A JP2013523827A (ja) 2013-06-17
JP2013523827A5 true JP2013523827A5 (enExample) 2014-04-03

Family

ID=44763261

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013503881A Pending JP2013523827A (ja) 2010-04-06 2011-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2015077340A Active JP6000397B2 (ja) 2010-04-06 2015-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2015237188A Withdrawn JP2016033164A (ja) 2010-04-06 2015-12-04 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2017194973A Withdrawn JP2017226706A (ja) 2010-04-06 2017-10-05 キトサン化合物を用いて創傷を処置するための方法および組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015077340A Active JP6000397B2 (ja) 2010-04-06 2015-04-06 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2015237188A Withdrawn JP2016033164A (ja) 2010-04-06 2015-12-04 キトサン化合物を用いて創傷を処置するための方法および組成物
JP2017194973A Withdrawn JP2017226706A (ja) 2010-04-06 2017-10-05 キトサン化合物を用いて創傷を処置するための方法および組成物

Country Status (7)

Country Link
US (5) US9439925B2 (enExample)
EP (1) EP2555760B1 (enExample)
JP (4) JP2013523827A (enExample)
AU (1) AU2011237682B2 (enExample)
CA (1) CA2795520C (enExample)
ES (1) ES2773017T3 (enExample)
WO (1) WO2011127144A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2848648C (en) 2006-06-02 2017-10-10 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
CA3004707C (en) 2009-09-02 2022-05-31 Synedgen Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
ES2773017T3 (es) 2010-04-06 2020-07-09 Synedgen Inc Derivados de quitosano para el tratamiento de mucositis o ulceración
US20150031610A1 (en) * 2012-03-05 2015-01-29 Synedgen, Inc. Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins
CN102755662B (zh) * 2012-07-25 2014-01-08 福州乾正药业有限公司 一种复合壳聚糖凝胶膜及其制备方法
US10022393B2 (en) * 2012-09-20 2018-07-17 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
TWI478943B (zh) * 2012-12-27 2015-04-01 Ind Tech Res Inst 高分子組成物用於製備具有抑制基質金屬蛋白酶之活性的功效的醫療器材或抑制劑的用途
CN103893813B (zh) * 2012-12-28 2018-04-17 财团法人工业技术研究院 高分子组合物与高分子材料
CA2905404C (en) 2013-03-12 2021-07-20 Synedgen, Inc. Oral formulations of polyglucosamine derivatives in combination with a non-fermentable sugar
WO2014172040A1 (en) * 2013-03-15 2014-10-23 Synedgen Inc. Compositions and methods of use for wound healing
WO2015022907A1 (ja) * 2013-08-13 2015-02-19 生化学工業株式会社 カチオン化キトサンを含有する医薬
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
AU2015314775A1 (en) 2014-09-11 2017-03-30 Synedgen, Inc. Compositions and methods of use thereof
CN108348455B (zh) * 2015-10-30 2021-04-09 克罗马药品股份有限公司 无菌水性眼用溶液的治疗用途
PL3368006T3 (pl) * 2015-10-30 2020-06-01 Croma-Pharma Gesellschaft M.B.H. Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego
EP3429602B1 (en) * 2016-03-16 2025-05-07 Synedgen, Inc. Compositions comprising a polyglucosamine-arginine and their use to treat dysbiosis
CN108096182A (zh) * 2016-11-25 2018-06-01 哈尔滨盈聚生物科技有限公司 一种基于绿色抗菌材料的妇科抗菌凝胶及其制备方法
US10918699B2 (en) * 2017-03-22 2021-02-16 Michael C. Struck Therapeutic treatment for neurotrophic keratopathy
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
TWI633888B (zh) * 2017-10-03 2018-09-01 黃琮瑋 醣類物質用於製備改善嗅覺功能的藥物之用途
CN107970269A (zh) * 2017-12-30 2018-05-01 广州润虹医药科技股份有限公司 一种含有壳聚糖的口腔溃疡膜及其制备方法
RU2697869C1 (ru) * 2018-04-28 2019-08-21 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Фармацевтическая субстанция для лечения инфицированных ран различного генеза
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
AU2020444897A1 (en) 2020-04-30 2022-12-08 Synedgen, Inc. Compositions and methods of use thereof
EP4406542A1 (en) 2023-01-26 2024-07-31 BioKuris Treatment of gut inflammatory diseases
WO2026128424A1 (en) * 2024-12-10 2026-06-18 Immunophotonics, Inc Compositions of chitosan and modified chitosans

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4532134A (en) 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
CA2181048C (en) * 1994-01-14 2003-05-06 Lee Shahinian, Jr. A method for sustained and extended corneal analgesia
US7214202B1 (en) 1997-07-28 2007-05-08 Kci Licensing, Inc. Therapeutic apparatus for treating ulcers
EP1061937A1 (en) 1998-03-10 2000-12-27 University Of Southern California Improved radiation therapy methods
PT1100344E (pt) 1998-07-30 2004-09-30 Vital Living Inc Novas composicoes liquidas contendo quitosana e metodos para a sua preparacao e utilizacao
US6114382A (en) 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
PT1128809E (pt) * 1998-11-20 2005-04-29 Medidom Lab Formulacoes oftalmicas aquosas comprendendo quitosano
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
JP2003012702A (ja) 2001-04-24 2003-01-15 Sankyo Co Ltd 低分子キトサンの製造方法
US20060127873A1 (en) 2002-07-16 2006-06-15 Caroline Hoemann Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
GB0302741D0 (en) 2003-02-06 2003-03-12 Advanced Biopolymers As Use
GB0303085D0 (en) 2003-02-11 2003-03-19 Pfizer Ltd Model
EP1771138A4 (en) 2004-07-26 2009-08-19 Kci Licensing Inc METHOD FOR COVERING ANTIMICROBIAL AGENT SUBSTRATE AND PRODUCT THUS FORMED
CN1965650A (zh) 2005-11-14 2007-05-23 陈祖辉 多元金属离子螯合的甲壳素绿色抗菌剂
CA2848648C (en) * 2006-06-02 2017-10-10 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
WO2009094172A2 (en) 2008-01-22 2009-07-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
WO2009136291A2 (en) * 2008-05-09 2009-11-12 Regenics As Cellular extracts
WO2010021930A1 (en) 2008-08-16 2010-02-25 Synedgen, Inc. Prevention and treatment of mrsa infections with chitosan-derivatives
CA2732438A1 (en) 2008-08-29 2010-03-04 The General Hospital Corporation Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
CA2743624C (en) 2008-11-12 2017-06-20 Synedgen, Inc. Chitosan derivatives to treat animals or optimize animal health
EP2387409A1 (en) 2008-11-12 2011-11-23 Synedgen, Inc. Chitosan derivatives alone or in combination for the treatment of mdr microbial infections
WO2010088565A1 (en) 2009-01-29 2010-08-05 Synedgen, Inc. Nucleic acid delivery using modified chitosans
AU2010259284A1 (en) 2009-06-10 2011-12-15 Exthera Ab Use of a composition for the treatment of mucositis
CA3004707C (en) 2009-09-02 2022-05-31 Synedgen Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
WO2011028968A1 (en) 2009-09-02 2011-03-10 Synedgen, Inc. Oral care methods and compositions utilizing chitosan-derivative compounds
ES2773017T3 (es) 2010-04-06 2020-07-09 Synedgen Inc Derivados de quitosano para el tratamiento de mucositis o ulceración
CA2840749A1 (en) 2011-07-01 2013-01-10 Synedgen, Inc. Methods and compositions of reducing and preventing bacterial growth and the formation of biofilm on a surface utilizing chitosan-derivative compounds
US8735571B2 (en) 2011-12-22 2014-05-27 Agenta Biotechnologies, Inc. Composition, preparation, and use of dense chitosan membrane materials
US20150031610A1 (en) 2012-03-05 2015-01-29 Synedgen, Inc. Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins
US10022393B2 (en) 2012-09-20 2018-07-17 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
CA2905404C (en) 2013-03-12 2021-07-20 Synedgen, Inc. Oral formulations of polyglucosamine derivatives in combination with a non-fermentable sugar
WO2014172040A1 (en) 2013-03-15 2014-10-23 Synedgen Inc. Compositions and methods of use for wound healing
AU2015314775A1 (en) 2014-09-11 2017-03-30 Synedgen, Inc. Compositions and methods of use thereof
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
US11390408B2 (en) 2020-11-24 2022-07-19 Axon Llc System and method for applying tubular bands to containers utilizing angled band ejection

Similar Documents

Publication Publication Date Title
Gatot et al. Effects of sodium hypochlorite on soft tissues after its inadvertent injection beyond the root apex
US9655840B2 (en) Wound care products
JP6027013B2 (ja) グルカン組成物
JP2006503044A5 (enExample)
EP2037908A2 (en) Method for treatment of wound using aganocides
CN105451745A (zh) 含有阳离子化壳聚糖的药物
KR20160067120A (ko) 비자가접착성 코팅 물질
JP2017501154A5 (enExample)
CN108478544A (zh) 一种黏膜疾病治疗系统及其应用
WO2011092715A3 (en) Method for in-vivo binding of chromatin fragments
RU2009107068A (ru) Применение пропиленгликоля при лечении связанных с воспалением местных нарушений или заболеваний и ран
Jia et al. Dynamic microenvironment-adaptable hydrogel with photothermal performance and ROS scavenging for management of diabetic ulcer
JP2014518272A5 (enExample)
CN108210689A (zh) 一种含有透明质酸的口腔溃疡膜剂及其制备方法
WO2021110063A1 (en) New conjugates of peptides and polysaccharide
PT1532986E (pt) Composição farmacêutica para o tratamento de rinite
EP4157290A1 (en) Compositions, their uses in therapy and methods thereof
WO1998029125A1 (fr) Remedes contre des troubles de la vessie
JP2012526099A5 (enExample)
CN112368304A (zh) 经取代的环糊精-金属络合物及其用途
RU2012116226A (ru) Бронхолитическое средство на основе простагландина
HUP0900717A2 (en) Pharmaceutical composition for urological use containing zinc hyaluronate
CN104740691A (zh) 一种医用生物胶体液及其制备方法
JP2016093467A (ja) 創傷治癒を促進し生体諸臓器の被覆(コーチング)及び庇護を目的とした生体皮膜剤。
WO2014155074A1 (en) Composition